Terms: = Prostate cancer AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II AND Prognosis
5 results:
1. Microvascular proliferation is associated with high tumour blood flow by mpMRI and disease progression in primary prostate cancer.
Børretzen A; Reisæter LAR; Ringheim A; Gravdal K; Haukaas SA; Fasmer KE; Haldorsen IHS; Beisland C; Akslen LA; Halvorsen OJ
Sci Rep; 2023 Oct; 13(1):17949. PubMed ID: 37863961
[TBL] [Abstract] [Full Text] [Related]
2. The cGAS-STING pathway-related gene signature can predict patient prognosis and immunotherapy responses in prostate adenocarcinoma.
Zhuo X; Dai H; Yu S
Medicine (Baltimore); 2022 Dec; 101(50):e31290. PubMed ID: 36550819
[TBL] [Abstract] [Full Text] [Related]
3. Identification of Cytosolic DNA Sensor cGAS-STING as Immune-Related Risk Factor in Renal Carcinoma following Pan-cancer Analysis.
Wu Z; Lin Y; Liu LM; Hou YL; Qin WT; Zhang L; Jiang SH; Yang Q; Bai YR
J Immunol Res; 2022; 2022():7978042. PubMed ID: 35983076
[TBL] [Abstract] [Full Text] [Related]
4. Functional characteristics and research trends of PDE11A in human diseases (Review).
Kong G; Lee H; Vo TT; Juang U; Kwon SH; Park J; Park J; Kim SH
Mol Med Rep; 2022 Oct; 26(4):. PubMed ID: 35929507
[TBL] [Abstract] [Full Text] [Related]
5. Increased expression of VEGF-receptors (FLT-1, KDR, NRP-1) and thrombospondin-1 is associated with glomeruloid microvascular proliferation, an aggressive angiogenic phenotype, in malignant melanoma.
Straume O; Akslen LA
Angiogenesis; 2003; 6(4):295-301. PubMed ID: 15166498
[TBL] [Abstract] [Full Text] [Related]
